FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 Jan 2021
Historique:
received: 16 12 2020
revised: 04 01 2021
accepted: 09 01 2021
entrez: 16 1 2021
pubmed: 17 1 2021
medline: 10 4 2021
Statut: epublish

Résumé

Cancer initiating cells (CICs) drive tumor formation and drug-resistance, but how they develop drug-resistance characteristics is not well understood. In this study, we demonstrate that chemotherapeutic agent FOLFOX, commonly used for drug-resistant/metastatic colorectal cancer (CRC) treatment, induces overexpression of CD44v6, MDR1, and oncogenic transcription/translation factor Y-box-binding protein-1 (YB-1). Our study revealed that CD44v6, a receptor for hyaluronan, increased the YB-1 expression through PGE2/EP1-mTOR pathway. Deleting CD44v6, and YB-1 by the CRISPR/Cas9 system attenuates the in vitro and in vivo tumor growth of CICs from FOLFOX resistant cells. The results of DNA:CD44v6 immunoprecipitated complexes by ChIP (chromatin-immunoprecipitation) assay showed that CD44v6 maintained the stemness traits by promoting several antiapoptotic and stemness genes, including

Identifiants

pubmed: 33451103
pii: ijms22020753
doi: 10.3390/ijms22020753
pmc: PMC7828641
pii:
doi:

Substances chimiques

ABCB1 protein, human 0
ATP Binding Cassette Transporter, Subfamily B 0
Biomarkers 0
CD44v6 antigen 0
Hyaluronan Receptors 0
Organoplatinum Compounds 0
Y-Box-Binding Protein 1 0
YBX1 protein, human 0
Leucovorin Q573I9DVLP
Fluorouracil U3P01618RT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Mol Biol Rep. 2019 Oct;46(5):5057-5062
pubmed: 31286390
Int J Oncol. 2014 Sep;45(3):1175-83
pubmed: 24926880
Biomed Pharmacother. 2013 Oct;67(8):791-9
pubmed: 24138824
Carcinogenesis. 2014 Apr;35(4):942-50
pubmed: 24325912
Oncology (Williston Park). 2000 Dec;14(12 Suppl 11):9-14
pubmed: 11204666
Cancer Cell. 2004 Sep;6(3):251-61
pubmed: 15380516
Stem Cells. 2009 May;27(5):1006-20
pubmed: 19415765
Genes Dev. 1998 Apr 1;12(7):1058-71
pubmed: 9531542
Blood. 2008 Apr 1;111(7):3714-22
pubmed: 18006704
Stem Cell Res Ther. 2019 Aug 2;10(1):233
pubmed: 31375149
Int J Oncol. 2014 Mar;44(3):769-80
pubmed: 24378923
Cell Stem Cell. 2012 Feb 3;10(2):111-2
pubmed: 22305559
J Biol Chem. 2009 May 1;284(18):12432-46
pubmed: 19246453
Nat Rev Cancer. 2007 Jun;7(6):415-28
pubmed: 17508028
Cell Stem Cell. 2014 Mar 6;14(3):342-56
pubmed: 24607406
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63
pubmed: 17548814
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Biochem J. 2013 Jan 1;449(1):11-23
pubmed: 23216250
Wiley Interdiscip Rev RNA. 2014 Jan-Feb;5(1):95-110
pubmed: 24217978
J Cell Physiol. 2005 Jun;203(3):583-8
pubmed: 15605406
Cell Stem Cell. 2014 Dec 4;15(6):692-705
pubmed: 25479747
J Cell Biol. 2001 Mar 19;152(6):1307-12
pubmed: 11257130
Development. 2016 Aug 1;143(15):2696-705
pubmed: 27486230
Nat Rev Cancer. 2005 Apr;5(4):275-84
pubmed: 15803154
Mol Cancer. 2017 Feb 16;16(1):41
pubmed: 28209166
Int J Oncol. 2016 Mar;48(3):1117-24
pubmed: 26782761
Nat Rev Cancer. 2009 Jan;9(1):40-55
pubmed: 19078974
Stem Cells. 2006 Jan;24(1):3-12
pubmed: 16449630
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
pubmed: 12629218
Int J Clin Exp Pathol. 2014 Dec 01;7(12):8715-23
pubmed: 25674237
PLoS One. 2014 Sep 03;9(9):e106966
pubmed: 25184276
Cancers (Basel). 2011 Feb 21;3(1):716-29
pubmed: 21643534
Mol Biol Cell. 2001 Feb;12(2):449-62
pubmed: 11179427
Cell Stem Cell. 2007 Jun 7;1(1):55-70
pubmed: 18371336
J Mol Histol. 2004 Mar;35(3):211-31
pubmed: 15339042
Cancer Res. 2003 Sep 15;63(18):5821-8
pubmed: 14522905
Cancer Res. 2002 Aug 1;62(15):4499-506
pubmed: 12154061
PLoS One. 2008;3(10):e3469
pubmed: 18941626
Oncogene. 2002 May 30;21(24):3898-908
pubmed: 12032828
Nat Rev Cancer. 2012 Jan 24;12(2):89-103
pubmed: 22270953
Annu Rev Med. 2007;58:267-84
pubmed: 17002552
PLoS One. 2013 Jul 16;8(7):e69760
pubmed: 23874993
Genes Dev. 1998 Jul 1;12(13):2048-60
pubmed: 9649508
Oncotarget. 2017 Dec 22;9(70):33403-33415
pubmed: 30279970
Nat Med. 2009 Sep;15(9):1010-2
pubmed: 19734877
Cancer Invest. 2009 Oct;27(8):844-50
pubmed: 19626493
Nat Biotechnol. 2013 Sep;31(9):827-32
pubmed: 23873081
Nature. 2017 Mar 29;543(7647):676-680
pubmed: 28358093
EMBO J. 2012 Jun 13;31(12):2685-96
pubmed: 22617424
Nat Cell Biol. 2006 Nov;8(11):1291-7
pubmed: 17028578
Stem Cells. 2017 Sep;35(9):2027-2036
pubmed: 28699179
Nat Med. 1997 Jul;3(7):730-7
pubmed: 9212098
Pharmgenomics Pers Med. 2017 Apr 20;10:129-142
pubmed: 28461764
F1000Res. 2016 Apr 19;5:
pubmed: 27134739
J Thorac Oncol. 2014 Jan;9(1):41-9
pubmed: 24346092
Cancer Sci. 2019 May;110(5):1536-1543
pubmed: 30903644
Stem Cells Int. 2018 Feb 28;2018:5416923
pubmed: 29681949
Cell. 2011 Oct 14;147(2):275-92
pubmed: 22000009
Exp Mol Pathol. 2004 Aug;77(1):18-25
pubmed: 15215046
J Gastrointest Surg. 2014 Nov;18(11):1987-93
pubmed: 25231080
Oncogene. 2008 Oct 27;27(50):6462-72
pubmed: 18955973
Gastroenterology. 2013 Sep;145(3):636-46.e5
pubmed: 23747337
Int J Cancer. 2015 May 1;136(9):1991-2000
pubmed: 24615680
Int J Cancer. 2009 Nov 15;125(10):2323-31
pubmed: 19598259
Cancer Lett. 2013 Sep 10;338(1):168-73
pubmed: 22429999
Nat Protoc. 2007;2(12):3081-9
pubmed: 18079707
Cancer Res. 2009 Mar 1;69(5):1951-7
pubmed: 19244128
J Biol Chem. 2007 Jul 6;282(27):19426-41
pubmed: 17493932
J Biol Chem. 2014 Mar 21;289(12):8545-61
pubmed: 24469446
Nat Genet. 2002 Dec;32(4):594-605
pubmed: 12426568
Nat Cell Biol. 2010 May;12(5):468-76
pubmed: 20418870
Matrix Biol. 2015 May-Jul;44-46:184-90
pubmed: 25661772
Connect Tissue Res. 2008;49(3):219-24
pubmed: 18661347
Lancet. 2010 Mar 20;375(9719):1030-47
pubmed: 20304247
CA Cancer J Clin. 2017 May 6;67(3):177-193
pubmed: 28248415
J Surg Oncol. 2012 Jun 1;105(7):724-30
pubmed: 22215526
Nat Rev Cancer. 2011 Apr;11(4):254-67
pubmed: 21390059
Nat Med. 2004 Jan;10(1):55-63
pubmed: 14702635
J Biol Chem. 2003 Jul 11;278(28):25285-8
pubmed: 12738783
J Cancer. 2017 Jul 1;8(10):1774-1785
pubmed: 28819374
Cancer Res. 2005 Apr 15;65(8):3025-9
pubmed: 15833827
Cancer Res. 2005 Dec 1;65(23):10946-51
pubmed: 16322242
Science. 2008 Aug 1;321(5889):699-702
pubmed: 18276851
Expert Rev Mol Diagn. 2012 Jul;12(6):621-8
pubmed: 22845482
Cell. 1998 Oct 30;95(3):379-91
pubmed: 9814708
Cell Death Differ. 2008 Mar;15(3):504-14
pubmed: 18049477
Cancer Res. 2010 Feb 1;70(3):1215-24
pubmed: 20103637
Cancer Cell. 2009 May 5;15(5):402-15
pubmed: 19411069
Br J Cancer. 2012 Jun 5;106(12):1901-6
pubmed: 22596239
Oncogene. 2009 Mar 19;28(11):1421-31
pubmed: 19151767
Cancer Res. 2005 Oct 15;65(20):9328-37
pubmed: 16230395
Oncogene. 2012 Jan 12;31(2):149-60
pubmed: 21685938
Medicine (Baltimore). 2016 Sep;95(1 Suppl 1):S2-S7
pubmed: 27611934
Methods Mol Biol. 2015;1239:197-217
pubmed: 25408407
Gastroenterology. 2013 Sep;145(3):647-57.e15
pubmed: 23684708
Front Cell Dev Biol. 2018 Aug 28;6:97
pubmed: 30211160
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13427-32
pubmed: 18765800
Nat Rev Cancer. 2013 Oct;13(10):727-38
pubmed: 24060864
EMBO J. 1999 Aug 2;18(15):4261-9
pubmed: 10428964
FASEB J. 2011 Jun;25(6):2022-30
pubmed: 21385990
J Biol Chem. 2005 Jul 1;280(26):24731-7
pubmed: 15860457
Int J Cancer. 2004 Mar 20;109(2):200-6
pubmed: 14750170
Front Surg. 2018 Jan 22;4:76
pubmed: 29404335
Cell. 2003 May 30;113(5):631-42
pubmed: 12787504
Genes Dev. 2002 Dec 1;16(23):3074-86
pubmed: 12464636
J Biol Chem. 2010 Jun 25;285(26):19821-32
pubmed: 20200161
Cancer Res. 2010 Apr 1;70(7):2840-51
pubmed: 20332234
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Nat Med. 2013 May;19(5):619-25
pubmed: 23584089
J Biol Chem. 2012 Jun 1;287(23):18995-9007
pubmed: 22433859
Cell Stem Cell. 2007 Sep 13;1(3):313-23
pubmed: 18371365
J Cell Biol. 2009 Jun 15;185(6):949-57
pubmed: 19506034
Expert Rev Anticancer Ther. 2010 Oct;10(10):1621-33
pubmed: 20942633
Oncogene. 2014 Jan 30;33(5):665-70
pubmed: 23318432
Nat Rev Cancer. 2007 Aug;7(8):573-84
pubmed: 17625587
Cell. 2009 Nov 25;139(5):871-90
pubmed: 19945376
J Biol Chem. 2005 Mar 11;280(10):8875-83
pubmed: 15632176
Nat Cell Biol. 2007 Jun;9(6):625-35
pubmed: 17515932
Front Cell Dev Biol. 2020 Jun 18;8:442
pubmed: 32626705
Nat Rev Cancer. 2005 Sep;5(9):744-9
pubmed: 16148886
Development. 2018 Mar 14;145(6):
pubmed: 29540464
Eur J Cardiothorac Surg. 2009 Sep;36(3):446-53
pubmed: 19464919
Stem Cells Dev. 2006 Oct;15(5):729-40
pubmed: 17105408
Cell Death Differ. 2008 Jun;15(6):947-58
pubmed: 18259194
Genes Cells. 2014 Jun;19(6):504-16
pubmed: 24774443
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12160-4
pubmed: 1465456
Development. 2007 Feb;134(4):635-46
pubmed: 17215298
Cancer Lett. 2008 Sep 8;268(1):1-9
pubmed: 18487012
Front Endocrinol (Lausanne). 2015 Apr 24;6:59
pubmed: 25964777
Hum Cell. 2006 Feb;19(1):24-9
pubmed: 16643604
Front Biosci (Schol Ed). 2012 Jan 01;4:819-30
pubmed: 22202093
Nat Cell Biol. 2001 Sep;3(9):802-8
pubmed: 11533659
J Biol Chem. 2008 May 23;283(21):14335-44
pubmed: 18326857
Yonsei Med J. 2018 Jan;59(1):35-42
pubmed: 29214774
Nat Genet. 2000 Apr;24(4):372-6
pubmed: 10742100
Cell. 2014 Jun 5;157(6):1262-1278
pubmed: 24906146
Mol Med Rep. 2015 Jun;11(6):4309-14
pubmed: 25633829
Nat Med. 2006 Aug;12(8):895-904
pubmed: 16892035
J Biol Chem. 2017 Jun 23;292(25):10465-10489
pubmed: 28389562
Clin Transl Oncol. 2015 Feb;17(2):152-9
pubmed: 25078572
N Engl J Med. 1993 Dec 30;329(27):1977-81
pubmed: 8247072
Nature. 2011 Dec 07;481(7379):85-9
pubmed: 22158103
Br J Surg. 2009 Oct;96(10):1196-204
pubmed: 19787768
Genes Dev. 2003 Jan 1;17(1):126-40
pubmed: 12514105
Eur J Cell Biol. 2014 Jan-Feb;93(1-2):61-70
pubmed: 24461929
Wiley Interdiscip Rev Dev Biol. 2017 May;6(3):
pubmed: 28251841
Nat Rev Cancer. 2012 Nov;12(11):767-75
pubmed: 23051844
J Mammary Gland Biol Neoplasia. 2001 Jul;6(3):287-97
pubmed: 11547898
Cancer Lett. 2012 Oct 1;323(1):106-113
pubmed: 22484497
J Biol Chem. 2017 Jun 23;292(25):10490-10519
pubmed: 28389561
BMC Cancer. 2014 May 09;14:328
pubmed: 24885403
Dev Cell. 2016 Sep 26;38(6):610-20
pubmed: 27676434
Oncotarget. 2017 May 09;8(37):62339-62348
pubmed: 28977949
Tumour Biol. 2016 Jul;37(7):8811-24
pubmed: 26747179
Blood. 2009 Dec 10;114(25):5236-44
pubmed: 19773544
Semin Cancer Biol. 2008 Aug;18(4):260-7
pubmed: 18467123
J Biol Chem. 2005 May 27;280(21):20310-5
pubmed: 15784621
Nat Cell Biol. 2013 Feb;15(2):126-34
pubmed: 23334500
Mol Cell Biol. 2000 Jan;20(2):672-83
pubmed: 10611246
PLoS One. 2020 Feb 13;15(2):e0228910
pubmed: 32053639
J Biol Chem. 2006 Nov 17;281(46):34936-41
pubmed: 16959784
Brain Tumor Pathol. 2008;25(2):67-72
pubmed: 18987831
Mol Carcinog. 2015 Nov;54(11):1252-63
pubmed: 25156912
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):40-5
pubmed: 20018687
PLoS One. 2008 Jun 18;3(6):e2428
pubmed: 18560594
Nat Med. 1997 Apr;3(4):447-50
pubmed: 9095180
Stem Cell Res. 2016 Mar;16(2):349-57
pubmed: 26896855
Biomed Pharmacother. 2019 Feb;110:473-481
pubmed: 30530050
Cell. 2006 Nov 17;127(4):679-95
pubmed: 17110329
Cell Stem Cell. 2007 Oct 11;1(4):389-402
pubmed: 18371377
J Biol Chem. 2014 Mar 14;289(11):7856-72
pubmed: 24324260
Surg Oncol Clin N Am. 2005 Oct;14(4):699-722
pubmed: 16226687
Science. 2007 Dec 21;318(5858):1917-20
pubmed: 18029452
Cancer Biomark. 2010;9(1-6):65-99
pubmed: 22112470
Cancer Res. 2012 Oct 1;72(19):5101-10
pubmed: 23002207
Oncol Lett. 2013 Nov;6(5):1174-1180
pubmed: 24179490
Cancer Res. 2009 Apr 15;69(8):3382-9
pubmed: 19336570
Cell. 2003 May 30;113(5):643-55
pubmed: 12787505

Auteurs

Shibnath Ghatak (S)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
Hollings Cancer Center, Department of Biochemistry and Molecular Biology, Medical University of South Carolina, 86 Jonathan Lucas St, Charleston, SC 29425, USA.

Vincent C Hascall (VC)

Department of Biomedical Engineering/ND20, Cleveland Clinic, Cleveland, OH 44195, USA.

Roger R Markwald (RR)

Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.

Suniti Misra (S)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
Hollings Cancer Center, Department of Biochemistry and Molecular Biology, Medical University of South Carolina, 86 Jonathan Lucas St, Charleston, SC 29425, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH